Literature DB >> 17367327

Uterine arteriovenous malformation: fertility-sparing surgery using unilateral ligation of uterine artery and ovarian ligament.

D Milingos1, D Doumplis, K Sieunarine, P Savage, A D Lawson, J R Smith.   

Abstract

Arteriovenous malformations (AVM) are rarely found in the uterus and are usually acquired. The method of treatment is determined by symptoms, desire for future fertility, extent, and location of the malformation. Selective ligation of the vessels supplying the malformation is an effective treatment option when conservative methods have failed and uterine preservation is of primary concern. Measurement of uterine O(2) saturation and perfusion index has been shown to be effective in the intraoperative assessment of uterine viability, pre- and postligation of pelvic vasculature. We present the case of a 32-year-old woman with a postmolar uterine AVM treated surgically with unilateral uterine artery and ovarian ligament ligation.

Entities:  

Mesh:

Year:  2007        PMID: 17367327     DOI: 10.1111/j.1525-1438.2007.00884.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  4 in total

1.  Failed angiographic embolization in uterine arteriovenous malformation: a case report and review of the literature.

Authors:  Rashmi Bagga; Preeti Verma; Neelam Aggarwal; Vanita Suri; J R Bapuraj; Naveen Kalra
Journal:  Medscape J Med       Date:  2008-01-16

2.  Hysteroscopic Management of Uterine Arteriovenous Malformation.

Authors:  Stefano Calzolari; Mauro Cozzolino; Eleonora Castellacci; Valeria Dubini; Alfonso Farruggia; Giovanni Sisti
Journal:  JSLS       Date:  2017 Apr-Jun       Impact factor: 2.172

3.  Embolization of uterine arteriovenous malformation.

Authors:  Yan Chen; Guoyun Wang; Fubo Xie; Bo Wang; Guowei Tao; Beihua Kong
Journal:  Iran J Reprod Med       Date:  2013-02

4.  A Systematic Review of Acquired Uterine Arteriovenous Malformations: Pathophysiology, Diagnosis, and Transcatheter Treatment.

Authors:  Daniel J Yoon; Megan Jones; Jamal Al Taani; Catalin Buhimschi; Joshua D Dowell
Journal:  AJP Rep       Date:  2015-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.